Literature DB >> 10594021

The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: two mechanisms for repression.

Y K Lee1, H Dell, D H Dowhan, M Hadzopoulou-Cladaras, D D Moore.   

Abstract

The orphan nuclear hormone receptor SHP interacts with a number of other nuclear hormone receptors and inhibits their transcriptional activity. Several mechanisms have been suggested to account for this inhibition. Here we show that SHP inhibits transactivation by the orphan receptor hepatocyte nuclear factor 4 (HNF-4) and the retinoid X receptor (RXR) by at least two mechanisms. SHP interacts with the same HNF-4 surface recognized by transcriptional coactivators and competes with them for binding in vivo. The minimal SHP sequences previously found to be required for interaction with other receptors are sufficient for interaction with HNF-4, although deletion results indicate that additional C-terminal sequences are necessary for full binding and coactivator competition. These additional sequences include those associated with direct transcriptional repressor activity of SHP. SHP also competes with coactivators for binding to ligand-activated RXR, and based on the ligand-dependent interaction with other nuclear receptors, it is likely that coactivator competition is a general feature of SHP-mediated repression. The minimal receptor interaction domain of SHP is sufficient for full interaction with RXR, as previously described. This domain is also sufficient for full coactivator competition. Functionally, however, full inhibition of RXR transactivation requires the presence of the C-terminal repressor domain, with only weak inhibition associated with this receptor interaction domain. Overall, these results suggest that SHP represses nuclear hormone receptor-mediated transactivation via two separate steps: first by competition with coactivators and then by direct effects of its transcriptional repressor function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10594021      PMCID: PMC85074          DOI: 10.1128/MCB.20.1.187-195.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

Review 1.  Orphan nuclear receptors--the first eight years.

Authors:  E Enmark; J A Gustafsson
Journal:  Mol Endocrinol       Date:  1996-11

2.  The transcriptional coactivators p300 and CBP are histone acetyltransferases.

Authors:  V V Ogryzko; R L Schiltz; V Russanova; B H Howard; Y Nakatani
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

3.  Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR.

Authors:  W Seol; M J Mahon; Y K Lee; D D Moore
Journal:  Mol Endocrinol       Date:  1996-12

4.  The CBP co-activator is a histone acetyltransferase.

Authors:  A J Bannister; T Kouzarides
Journal:  Nature       Date:  1996 Dec 19-26       Impact factor: 49.962

5.  Activation of the promoter of the orphan receptor SHP by orphan receptors that bind DNA as monomers.

Authors:  Y K Lee; K L Parker; H S Choi; D D Moore
Journal:  J Biol Chem       Date:  1999-07-23       Impact factor: 5.157

6.  Functional domains of the nuclear receptor hepatocyte nuclear factor 4.

Authors:  M Hadzopoulou-Cladaras; E Kistanova; C Evagelopoulou; S Zeng; C Cladaras; J A Ladias
Journal:  J Biol Chem       Date:  1997-01-03       Impact factor: 5.157

7.  Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily.

Authors:  F M Sladek; W M Zhong; E Lai; J E Darnell
Journal:  Genes Dev       Date:  1990-12       Impact factor: 11.361

8.  Mutations that alter ligand-induced switches and dimerization activities in the retinoid X receptor.

Authors:  X K Zhang; G Salbert; M O Lee; M Pfahl
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

9.  The directly repeated RG(G/T)TCA motifs of the rat and mouse cellular retinol-binding protein II genes are promiscuous binding sites for RAR, RXR, HNF-4, and ARP-1 homo- and heterodimers.

Authors:  H Nakshatri; P Chambon
Journal:  J Biol Chem       Date:  1994-01-14       Impact factor: 5.157

10.  Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors.

Authors:  P S Danielian; R White; J A Lees; M G Parker
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

View more
  86 in total

1.  Dissecting the transcriptional network of pancreatic islets during development and differentiation.

Authors:  D Q Shih; M Stoffel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-04       Impact factor: 11.205

2.  Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation.

Authors:  J P Hernandez; L C Mota; W S Baldwin
Journal:  Curr Pharmacogenomics Person Med       Date:  2009-06-01

Review 3.  Role of nuclear receptor SHP in metabolism and cancer.

Authors:  Yuxia Zhang; Curt H Hagedorn; Li Wang
Journal:  Biochim Biophys Acta       Date:  2010-10-20

Review 4.  Cell signaling and nuclear receptors: new opportunities for molecular pharmaceuticals in liver disease.

Authors:  Jeff L Staudinger; Kristin Lichti
Journal:  Mol Pharm       Date:  2007-12-27       Impact factor: 4.939

5.  FGF15/FGFR4 integrates growth factor signaling with hepatic bile acid metabolism and insulin action.

Authors:  Dong-Ju Shin; Timothy F Osborne
Journal:  J Biol Chem       Date:  2009-02-23       Impact factor: 5.157

6.  Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis.

Authors:  Sushant Bhatnagar; Holly A Damron; F Bradley Hillgartner
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

Review 7.  Hepatocyte nuclear factor 4alpha regulation of bile acid and drug metabolism.

Authors:  John Y L Chiang
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-02       Impact factor: 4.481

8.  MicroRNAs regulate human hepatocyte nuclear factor 4alpha, modulating the expression of metabolic enzymes and cell cycle.

Authors:  Shingo Takagi; Miki Nakajima; Katsuhiko Kida; Yu Yamaura; Tatsuki Fukami; Tsuyoshi Yokoi
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

9.  Repression of hepatocyte nuclear factor 4 alpha by AP-1 underlies dyslipidemia associated with retinoic acid.

Authors:  Kyoung-Jae Won; Joo-Seop Park; Hyunyoung Jeong
Journal:  J Lipid Res       Date:  2019-02-01       Impact factor: 5.922

10.  Peroxisome proliferator-activated receptor-gamma coactivator-1alpha activation of CYP7A1 during food restriction and diabetes is still inhibited by small heterodimer partner.

Authors:  Dong-Ju Shin; Timothy F Osborne
Journal:  J Biol Chem       Date:  2008-04-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.